Nephrogenic Systemic Fibrosis in a Patient With Multiple Inflammatory Disorders.
| Autor: | Chuang K; is a Chief Resident in the University of California Department of Medicine in Los Angeles. is a Hospitalist, and is a Pulmonologist at West Los Angeles VAMC Medical Center in California., Kaneshiro C; is a Chief Resident in the University of California Department of Medicine in Los Angeles. is a Hospitalist, and is a Pulmonologist at West Los Angeles VAMC Medical Center in California., Betancourt J; is a Chief Resident in the University of California Department of Medicine in Los Angeles. is a Hospitalist, and is a Pulmonologist at West Los Angeles VAMC Medical Center in California. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Federal practitioner : for the health care professionals of the VA, DoD, and PHS [Fed Pract] 2018 Jun; Vol. 35 (6), pp. 40-43. |
| Abstrakt: | The risk of developing nephrogenic systemic fibrosis in patients with end stage renal disease may increase with exposure to gadolinium-based contrast dyes during magnetic resonance imaging. Competing Interests: Author disclosures The authors report no actual or potential conflicts of interest with regard to this article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|